Comparison

Fraxetin European Partner

Item no. TMO-T2909-25mg
Manufacturer TargetMol
CASRN 574-84-5
Amount 25 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9889
Citations 1. Wang H, et al. Mol Med Rep. 2014 Nov;10(5):2341-5.
Smiles COc1cc2ccc(=O)oc2c(O)c1O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 7,8-dihydroxy-6-methoxy coumarin
Similar products 574-84-5
Shipping Condition Cool pack
Available
Manufacturer - Targets
Apoptosis
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
208.17
Description
Fraxetin (7, 8-dihydroxy-6-methoxy coumarin) has dual-antioxidative , hepatoprotective and antihyperglycemic functions, it shows potent protective effects against CCl4 induced oxidative stress and hepatic fibrosis, has a marked inhibitory effect on S.aureus proliferation. It increased the level of Nrf2/ARE, and HO-1, inhibit the formation of ROS, cytochrome c release, activation of caspase-3 and 9, and suppressed the up-regulation of Bax.
Pathways
Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close